3) reduce the dose of oral minoxidil to 1.25 mg or 1.875 mg and add spironolactone 50-100 mg and topical minoxidil if there are no contraindications and the patient accepts the potential side effects
LFQ proteomic analysis provides revealing insight into the putative mechanisms facilitating this observation
Jardiance family Disease area(s): Metabolic/cardiovascular Manufacturer(s): Boehringer Ingelheim/Eli Lilly and Company 2024 Sales (USD): $12.38 billion Why it sold so well: Co-developed by Boehringer Ingelheim and Eli Lilly, the Jardiance family experienced robust growth in 2024, driven by expanding clinical indications and strong global demand
Lactic acid bacteria as a cell factory for riboflavin production
At Southern Care Anesthetics, BPC-157 is used as part of a comprehensive treatment plan to help patients recover more quickly and efficiently from joint pain and ligament injuries, improving their mobility and quality of life
Final Thoughts: Peptides as a Tool, Not a Cure Peptides are fascinating molecules that show real potential in supporting wellness, recovery, and age-related changes